Synergy Bioscience

Executive Summary

Synergy Bioscience is a fully-integrated Contract Research, Development, Manufacturing, Testing, and Consulting Organization (CRDMO) headquartered in San Diego, California. Founded in 2016, the company offers end-to-end services for pharmaceutical and medical device development, including analytical chemistry, microbiology testing, formulation studies, and regulatory compliance consulting. Its capabilities span small molecules, biologics, antibodies, and medical devices, enabling clients to progress from concept to commercialization under one roof. As a private, pre-clinical stage company, Synergy Bioscience positions itself as a reliable partner for emerging biotech and established pharma companies seeking outsourced R&D and manufacturing solutions. With the growing demand for specialized CRDMO services, particularly in the biologics and antibody space, Synergy Bioscience is well-placed to capture market share. The company's integrated model reduces client timelines and costs, while its regulatory expertise ensures compliance with FDA and global standards. Although private and with limited public financial disclosures, the company's focus on quality and comprehensive service offerings suggests steady growth potential. Key near-term catalysts include potential facility expansions, new service launches, and strategic collaborations that could significantly boost its client base and revenue.

Upcoming Catalysts (preview)

• Q3 2026Expansion of biologics manufacturing capacity70% success
• Q3 2026Strategic partnership with a mid-size pharma company50% success
• Q4 2026Launch of new analytical testing service for antibodies60% success